Acute Myeloid Leukemia Developing with Acute Pancreatitis Mimicking Autoimmune Pancreatitis

por Sumitani, Ryohei, Hori, Taiki, Murai, Jumpei, Kawata, Shiyori, Oura, Masahiro, Sogabe, Kimiko, Takahashi, Mamiko, Harada, Takeshi, Fujii, Shiro, Miki, Hirokazu, Kagawa, Kumiko, Abe, Masahiro, Nakamura, Shingen
Publicado 2021

Mechanical unloading aggravates bone destruction and tumor expansion in myeloma

por Tanimoto, Kotaro, Hiasa, Masahiro, Tenshin, Hirofumi, Teramachi, Jumpei, Oda, Asuka, Harada, Takeshi, Higa, Yoshiki, Sogabe, Kimiko, Oura, Masahiro, Sumitani, Ryohei, Hara, Tomoyo, Endo, Itsuro, Matsumoto, Toshio, Tanaka, Eiji, Abe, Masahiro
Publicado 2021

The importance of retaining physical functions to prevent skeletal‐related events in multiple myeloma patients with bone disease

por Miki, Hirokazu, Nakamura, Shingen, Oura, Masahiro, Nakamura, Masafumi, Sumitani, Ryohei, Sogabe, Kimiko, Takahashi, Mamiko, Maruhashi, Tomoko, Harada, Takeshi, Fujii, Shiro, Hamano, Hirofumi, Kondo, Masateru, Okada, Naoto, Endo, Itsuro, Abe, Masahiro
Publicado 2022

PD-L1 upregulation in myeloma cells by panobinostat in combination with interferon-γ

por Iwasa, Masami, Harada, Takeshi, Oda, Asuka, Bat-Erdene, Ariunzaya, Teramachi, Jumpei, Tenshin, Hirofumi, Ashtar, Mohannad, Oura, Masahiro, Sogabe, Kimiko, Udaka, Kengo, Fujii, Shiro, Nakamura, Shingen, Miki, Hirokazu, Kagawa, Kumiko, Ozaki, Shuji, Abe, Masahiro
Publicado 2019

Synergistic targeting of Sp1, a critical transcription factor for myeloma cell growth and survival, by panobinostat and proteasome inhibitors

por Bat-Erdene, Ariunzaya, Miki, Hirokazu, Oda, Asuko, Nakamura, Shingen, Teramachi, Jumpei, Amachi, Ryota, Tenshin, Hirofumi, Hiasa, Masahiro, Iwasa, Masami, Harada, Takeshi, Fujii, Shiro, Sogabe, Kimiko, Kagawa, Kumiko, Yoshida, Sumiko, Endo, Itsuro, Aihara, Kenichi, Abe, Masahiro
Publicado 2016

Mechanisms of preferential bone formation in myeloma bone lesions by proteasome inhibitors

por Nakaue, Emiko, Teramachi, Jumpei, Tenshin, Hirofumi, Hiasa, Masahiro, Harada, Takeshi, Oda, Asuka, Inoue, Yusuke, Shimizu, So, Higa, Yoshiki, Sogabe, Kimiko, Oura, Masahiro, Hara, Tomoyo, Sumitani, Ryohei, Maruhashi, Tomoko, Yamagami, Hiroki, Endo, Itsuro, Tanaka, Eiji, Abe, Masahiro
Publicado 2023

Novel antimyeloma therapeutic option with inhibition of the HDAC1-IRF4 axis and PIM kinase

por Harada, Takeshi, Ohguchi, Hiroto, Oda, Asuka, Nakao, Michiyasu, Teramachi, Jumpei, Hiasa, Masahiro, Sumitani, Ryohei, Oura, Masahiro, Sogabe, Kimiko, Maruhashi, Tomoko, Takahashi, Mamiko, Fujii, Shiro, Nakamura, Shingen, Miki, Hirokazu, Kagawa, Kumiko, Ozaki, Shuji, Sano, Shigeki, Hideshima, Teru, Abe, Masahiro
Publicado 2022

Reveromycin A, a novel acid-seeking agent, ameliorates bone destruction and tumor growth in multiple myeloma

por Watanabe, Keiichiro, Bat-Erdene, Ariunzaya, Tenshin, Hirofumi, Cui, Qu, Teramachi, Jumpei, Hiasa, Masahiro, Oda, Asuka, Harada, Takeshi, Miki, Hirokazu, Sogabe, Kimiko, Oura, Masahiro, Sumitani, Ryohei, Mitsui, Yukari, Endo, Itsuro, Tanaka, Eiji, Kawatani, Makoto, Osada, Hiroyuki, Matsumoto, Toshio, Abe, Masahiro
Publicado 2021

TAK1 is a pivotal therapeutic target for tumor progression and bone destruction in myeloma

por Teramachi, Jumpei, Tenshin, Hirofumi, Hiasa, Masahiro, Oda, Asuka, Bat-Erdene, Ariunzaya, Harada, Takeshi, Nakamura, Shingen, Ashtar, Mohannad, Shimizu, So, Iwasa, Masami, Sogabe, Kimiko, Oura, Masahiro, Fujii, Shiro, Kagawa, Kumiko, Miki, Hirokazu, Endo, Itsuro, Haneji, Tatsuji, Matsumoto, Toshio, Abe, Masahiro
Publicado 2020

Therapeutic efficacy of the resorcylic acid lactone LL‐Z1640‐2 for adult T‐cell leukaemia/lymphoma

por Oura, Masahiro, Harada, Takeshi, Oda, Asuka, Teramachi, Jumpei, Nakayama, Atsushi, Sumitani, Ryohei, Inoue, Yusuke, Maeda, Yusaku, Sogabe, Kimiko, Maruhashi, Tomoko, Takahashi, Mamiko, Fujii, Shiro, Nakamura, Shingen, Miki, Hirokazu, Nakamura, Masafumi, Hara, Tomoyo, Yamagami, Hiroki, Kurahashi, Kiyoe, Endo, Itsuro, Hasegawa, Hiroo, Fujiwara, Hiroshi, Abe, Masahiro
Publicado 2023

TGF‐β‐activated kinase‐1 inhibitor LL‐Z1640‐2 reduces joint inflammation and bone destruction in mouse models of rheumatoid arthritis by inhibiting NLRP3 inflammasome, TACE, TNF‐α...

por Tenshin, Hirofumi, Teramachi, Jumpei, Ashtar, Mohannad, Hiasa, Masahiro, Inoue, Yusuke, Oda, Asuka, Tanimoto, Kotaro, Shimizu, So, Higa, Yoshiki, Harada, Takeshi, Oura, Masahiro, Sogabe, Kimiko, Hara, Tomoyo, Sumitani, Ryohei, Maruhashi, Tomoko, Sebe, Mayu, Tsutsumi, Rie, Sakaue, Hiroshi, Endo, Itsuro, Matsumoto, Toshio, Tanaka, Eiji, Abe, Masahiro
Publicado 2022

The Xanthine Oxidase Inhibitor Febuxostat Suppresses Adipogenesis and Activates Nrf2

por Higa, Yoshiki, Hiasa, Masahiro, Tenshin, Hirofumi, Nakaue, Emiko, Tanaka, Mariko, Kim, Sooha, Nakagawa, Motosumi, Shimizu, So, Tanimoto, Kotaro, Teramachi, Jumpei, Harada, Takeshi, Oda, Asuka, Oura, Masahiro, Sogabe, Kimiko, Hara, Tomoyo, Sumitani, Ryohei, Maruhashi, Tomoko, Yamagami, Hiroki, Endo, Itsuro, Matsumoto, Toshio, Tanaka, Eiji, Abe, Masahiro
Publicado 2023

The Roles of ROS Generation in RANKL-Induced Osteoclastogenesis: Suppressive Effects of Febuxostat

por Ashtar, Mohannad, Tenshin, Hirofumi, Teramachi, Jumpei, Bat-Erdene, Ariunzaya, Hiasa, Masahiro, Oda, Asuka, Tanimoto, Kotaro, Shimizu, So, Higa, Yoshiki, Harada, Takeshi, Oura, Masahiro, Sogabe, Kimiko, Nakamura, Shingen, Fujii, Shiro, Sumitani, Ryohei, Miki, Hirokazu, Udaka, Kengo, Takahashi, Mamiko, Kagawa, Kumiko, Endo, Itsuro, Tanaka, Eiji, Matsumoto, Toshio, Abe, Masahiro
Publicado 2020